Southpoint Capital Advisors LP
Position in TMO — Thermo Fisher Scientific Inc.
CIK 1319998
NEW YORK, NY
Position in TMO
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$250,680,000
+$54,068,000 QoQ
Shares Held
500,000
+25.0% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
5.70%
of 13F equity value
Holder Rank
#102
of 2,605 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TMO Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Southpoint Capital Advisors LP holds $587,684,000 across 3 Diagnostics & Research names. TMO ranks #2 (42.7% of the industry book) .
All Filings in TMO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $250,680,000 | 500,000 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $196,612,000 | 400,000 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $57,945,000 | 100,000 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $194,008,000 | 400,000 | Shares | Defined | 2025-11-14 | |
| No filing history on record for this holder in this stock. | ||||||